GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Ltd Board Approves Q1 FY27 Unaudited Results and AGM Details

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 31 Jul 2026, 05:31 PM IST  ·  BSE ID: 7c01a2ea-a3f4-4c65-b6d6-1096f951dba3
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors met to approve financial results and plan the upcoming annual meeting and dividend.
🤖 AI Summary
  • SMS Pharmaceuticals approved Q1 FY27 un-audited financial results on July 31, 2026.
  • The 38th Annual General Meeting is scheduled for September 23, 2026.
  • Record date for dividend eligibility for FY25-26 is September 16, 2026.
  • Member register closes September 17-23, 2026, for AGM purposes.
🔢 Key Numbers — exact figures from BSE filing, not rounded
AGM Date
23rd September, 2026
Record Date
16th September, 2026
Book Closure Start
17th September, 2026
Book Closure End
23rd September, 2026
🏢 How This Affects the Company
💰
Financial Impact
The company has disclosed its un-audited financial results for the first quarter of FY27.
⚙️
Operational Impact
The company has scheduled its 38th Annual General Meeting and defined processes for shareholder participation and dividend eligibility.
👥 What This Means For Shareholders
✅
Action Required
Shareholders do not need to take any action at this time unless they wish to attend the AGM.
👤
Who Is Affected
All shareholders of record as of September 16, 2026, are eligible for the dividend, if approved.
🔍
Management Signal
Management is adhering to standard corporate governance timelines and regulatory requirements for financial reporting and shareholder meetings.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Full Q1 FY27 results disclosure with financial statement details.
Outcome of the 38th Annual General Meeting on September 23, 2026.
Announcement regarding dividend payment if approved at the AGM.
LOW RISK The filing details routine corporate governance and financial reporting events.
💡 Investor Takeaway
SMS Pharmaceuticals Ltd approved Q1 FY27 un-audited results and set the AGM date for September 23, 2026, with a record date of September 16, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Successful scheduling of the 38th AGM ensures continued corporate governance and shareholder engagement.
  • Clear definition of record date and book closure facilitates timely dividend payment to eligible shareholders.
❓ Frequently Asked Questions
When is SMS Pharmaceuticals Ltd's 38th Annual General Meeting?
The 38th Annual General Meeting for the Financial Year 2025-26 is scheduled for Wednesday, 23rd September, 2026.
What is the record date for SMS Pharmaceuticals Ltd's dividend?
The record date for determining members eligible to receive dividend for FY25-26 is Wednesday, 16th September, 2026.
When will SMS Pharmaceuticals Ltd's Register of Members be closed?
The Register of Member and Share Transfer Books will remain closed from Thursday, 17th September, 2026, to Wednesday, 23rd September, 2026, inclusive.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.